Rhonda C. Kines

2.2k total citations
22 papers, 1.7k citations indexed

About

Rhonda C. Kines is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Rhonda C. Kines has authored 22 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Rhonda C. Kines's work include Cervical Cancer and HPV Research (12 papers), Immunotherapy and Immune Responses (9 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Rhonda C. Kines is often cited by papers focused on Cervical Cancer and HPV Research (12 papers), Immunotherapy and Immune Responses (9 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Rhonda C. Kines collaborates with scholars based in United States, Netherlands and Malaysia. Rhonda C. Kines's co-authors include John T. Schiller, Patricia M. Day, Douglas R. Lowy, Cynthia D. Thompson, Jeffrey N. Roberts, Christopher B. Buck, Marcelino Bernardo, Peter L. Choyke, Katherine M. Johnson and Yuk‐Ying S. Pang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Rhonda C. Kines

21 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rhonda C. Kines United States 15 1.0k 640 332 281 183 22 1.7k
Jeffrey N. Roberts United States 12 909 0.9× 442 0.7× 287 0.9× 221 0.8× 101 0.6× 16 1.5k
Ratish Gambhira United States 16 1.1k 1.0× 671 1.0× 230 0.7× 251 0.9× 91 0.5× 23 1.3k
Nancy M. Cladel United States 23 1.2k 1.1× 575 0.9× 305 0.9× 399 1.4× 143 0.8× 50 1.5k
Sabine Brandt Austria 27 1.2k 1.2× 896 1.4× 460 1.4× 330 1.2× 209 1.1× 72 2.5k
Timothy D. Culp United States 17 957 0.9× 440 0.7× 220 0.7× 269 1.0× 105 0.6× 23 1.2k
Merilyn Hibma New Zealand 22 810 0.8× 412 0.6× 376 1.1× 273 1.0× 283 1.5× 56 1.4k
Diane M. Da Silva United States 28 1.0k 1.0× 1.2k 1.9× 531 1.6× 237 0.8× 418 2.3× 63 2.1k
D R Lowy United States 9 1.2k 1.2× 551 0.9× 248 0.7× 326 1.2× 111 0.6× 12 1.5k
Andreas Kleinheinz Germany 14 1.2k 1.1× 381 0.6× 479 1.4× 360 1.3× 302 1.7× 28 1.9k

Countries citing papers authored by Rhonda C. Kines

Since Specialization
Citations

This map shows the geographic impact of Rhonda C. Kines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhonda C. Kines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhonda C. Kines more than expected).

Fields of papers citing papers by Rhonda C. Kines

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhonda C. Kines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhonda C. Kines. The network helps show where Rhonda C. Kines may publish in the future.

Co-authorship network of co-authors of Rhonda C. Kines

This figure shows the co-authorship network connecting the top 25 collaborators of Rhonda C. Kines. A scholar is included among the top collaborators of Rhonda C. Kines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhonda C. Kines. Rhonda C. Kines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Fons, Nathan R., Rhonda C. Kines, Cynthia D. Thompson, et al.. (2022). Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions. Journal of Virology. 96(7). e0185721–e0185721. 10 indexed citations
4.
Kines, Rhonda C. & John T. Schiller. (2022). Harnessing Human Papillomavirus’ Natural Tropism to Target Tumors. Viruses. 14(8). 1656–1656. 8 indexed citations
5.
Kines, Rhonda C., et al.. (2022). A novel virus-like drug conjugate (VDC) in combination with immune checkpoint inhibitors for the treatment of primary tumors and distant metastasis.. Journal of Clinical Oncology. 40(16_suppl). e14544–e14544. 3 indexed citations
6.
Kines, Rhonda C., et al.. (2021). Virus-Like Particle–Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor Antigens. Cancer Immunology Research. 9(6). 693–706. 27 indexed citations
7.
Kines, Rhonda C., Isabella Varsavsky, Debaditya Bhattacharya, et al.. (2017). An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma. Molecular Cancer Therapeutics. 17(2). 565–574. 45 indexed citations
8.
Kines, Rhonda C., Vladimir Zarnitsyn, Teresa R. Johnson, et al.. (2015). Vaccination with Human Papillomavirus Pseudovirus-Encapsidated Plasmids Targeted to Skin Using Microneedles. PLoS ONE. 10(3). e0120797–e0120797. 40 indexed citations
9.
Kines, Rhonda C., et al.. (2015). Human papillomavirus capsids preferentially bind and infect tumor cells. International Journal of Cancer. 138(4). 901–911. 34 indexed citations
10.
Çuburu, Nicolas, Barney S. Graham, Christopher B. Buck, et al.. (2012). Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. Journal of Clinical Investigation. 122(12). 4606–4620. 106 indexed citations
11.
Day, Patricia M., Yuk‐Ying S. Pang, Rhonda C. Kines, et al.. (2012). A Human Papillomavirus (HPV) In Vitro Neutralization Assay That Recapitulates the In Vitro Process of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies. Clinical and Vaccine Immunology. 19(7). 1075–1082. 74 indexed citations
12.
Mitsunaga, Makoto, Nobuyuki Kosaka, Rhonda C. Kines, et al.. (2011). In Vivo Longitudinal Imaging of Experimental Human Papillomavirus Infection in Mice with a Multicolor Fluorescence Mini-Endoscopy System. Cancer Prevention Research. 4(5). 767–773. 14 indexed citations
13.
Roberts, Jeffrey N., Rhonda C. Kines, Hormuzd A. Katki, Douglas R. Lowy, & John T. Schiller. (2011). Effect of Pap Smear Collection and Carrageenan on Cervicovaginal Human Papillomavirus-16 Infection in a Rhesus Macaque Model. JNCI Journal of the National Cancer Institute. 103(9). 737–743. 42 indexed citations
14.
Day, Patricia M., Rhonda C. Kines, Cynthia D. Thompson, et al.. (2010). In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection. Cell Host & Microbe. 8(3). 260–270. 122 indexed citations
15.
Graham, Barney S., Rhonda C. Kines, Kizzmekia S. Corbett, et al.. (2010). Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Mucosal Immunology. 3(5). 475–486. 23 indexed citations
17.
Schiller, John T., Patricia M. Day, & Rhonda C. Kines. (2010). Current understanding of the mechanism of HPV infection. Gynecologic Oncology. 118(1). S12–S17. 235 indexed citations
18.
Kines, Rhonda C., Cynthia D. Thompson, Douglas R. Lowy, John T. Schiller, & Patricia M. Day. (2009). The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proceedings of the National Academy of Sciences. 106(48). 20458–20463. 213 indexed citations
19.
Johnson, Katherine M., Rhonda C. Kines, Jeffrey N. Roberts, et al.. (2008). Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human Papillomavirus. Journal of Virology. 83(5). 2067–2074. 185 indexed citations
20.
Roberts, Jeffrey N., Christopher B. Buck, Cynthia D. Thompson, et al.. (2007). Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nature Medicine. 13(7). 857–861. 394 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026